Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
about
Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.Dietary lignans: physiology and potential for cardiovascular disease risk reduction.Sodium hydrosulfide prevents myocardial dysfunction through modulation of extracellular matrix accumulation and vascular densityCardioprotective activity of flax lignan concentrate extracted from seeds of Linum usitatissimum in isoprenalin induced myocardial necrosis in ratsStrategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor.Adverse impact of diet-induced hypercholesterolemia on cardiovascular tissue homeostasis in a rabbit model: time-dependent changes in cardiac parametersPostischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium.Maternal exposure to diets containing flaxseed flour or flaxseed oil during pregnancy and lactation protects the aortic remodeling in adult male offspring of diabetic rat dams.Prolonged administration of secoisolariciresinol diglycoside increases lignan excretion and alters lignan tissue distribution in adult male and female rats.Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats.Secoisolariciresinol diglucoside attenuates cardiac hypertrophy and oxidative stress in monocrotaline-induced right heart dysfunction.Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation.Protective Role of Flaxseed Oil and Flaxseed Lignan Secoisolariciresinol Diglucoside Against Oxidative Stress in Rats with Metabolic Syndrome.Hemorheological effects of secoisolariciresinol in ovariectomized rats.
P2860
Q34020533-EA1B2223-8C48-4109-B8E2-3A3E6BD80DEBQ34140938-C63C9203-60E7-4DE1-8AAC-9AE710F7AC66Q34835381-E13976C0-A519-4C0C-B986-CCF8E2087A5BQ35092035-22C0BC3F-29B4-4070-A7E5-2388008876E0Q36984711-284A803B-BE01-49DD-A778-CB9FB8D2608EQ37225267-7FAD6656-9579-4177-B80F-D46DD3C99EB1Q37568669-2ED37448-6EF1-425E-B23E-87ABCE4ED90BQ41719445-DBE63F1E-2E06-4E49-9445-465E891F54B3Q43101262-0DB564D5-2599-40F4-A597-C80182D3F971Q43179396-7B71599D-CA62-4409-A7E5-9E85FA8CC279Q44871137-29560960-0DEB-4488-954E-DA8CB161DC7BQ47551500-3B223E10-C948-4E00-ABEA-F68DFC9FD3E5Q47588570-D99A6463-B4B2-422A-B6F1-72A911CC5572Q50943376-77D87672-E39D-4636-A543-467314356751
P2860
Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@en
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@nl
type
label
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@en
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@nl
prefLabel
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@en
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@nl
P2093
P2860
P921
P1476
Secoisolariciresinol diglucosi ...... percholesterolemic myocardium.
@en
P2093
Kailash Prasad
Lijun Zhan
Nilanjana Maulik
Srikanth Koneru
Suresh Varma Penumathsa
Venogopal P Menon
P2860
P304
P356
10.1016/J.YJMCC.2007.09.014
P577
2007-10-04T00:00:00Z